BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sciona Limited Appoints Roy Whitfield To Board Of Directors


10/19/2005 5:08:54 PM

BOULDER, Colo., June 14 /PRNewswire/ -- Sciona, an international, privately held biotechnology company and a world leader in the development and commercialization of personalized genetic information, named Roy Whitfield to its board of directors and appointed him chairman of the company's Science and Business Advisory Board.

"With the recent successful launch and uptake of the Cellf(TM) test in the U.S., Sciona is bringing genomics directly to consumers, empowering them to make better nutritional and lifestyle decisions," said Whitfield. "I believe a significant and early component of the commercial promise of genomic technologies will be realized in the field of nutrigenomics, and Sciona is demonstrating that."

As a Sciona board member, Whitfield will focus on public policy, intellectual property and business development issues. Whitfield brings over 20 years of management and governance experience in the biotechnology industry. Most recently, Whitfield served as CEO and Chairman of Incyte Corporation, a genomics company he co-founded in 1991. Incyte pioneered the commercialization of high throughput and information technology in pharmaceutical and medical research. At Incyte, Whitfield executed the first genomics initial public offering (IPO) and later raised over $700 million in financing. Whitfield received the 1997 Northern California Entrepreneur of the Year Award for Life Sciences and the 1996 Best of Biotech Award for Most Creative and Significant Strategic Alliances. Whitfield's governance experience includes the boards of Incyte Corporation, Nektar Therapeutics, Aurora Biosciences and the Biotechnology Industry Organization (BIO).

"Mr. Whitfield's industry experience and vision will be of great benefit to Sciona as we rapidly bring to consumers technologies and applications he brought to the pharmaceutical industry," said James Bruce, president and CEO of Sciona.

Sciona recently concluded its Series C financing. Burrill and Company led the round, which also included investors Prelude Trust, BASF Venture Capital Gmbh and Bioventures, Inc.

Sciona develops DNA tests for identified genes that can affect changes in lifestyle and wellness choices. These nutritional genetic tests serve as the basis for providing personalized, science-based health and lifestyle advice to consumers. Sciona develops the Cellf(TM) nutritional genetic test, which provides consumers with nutritional guidelines -- based on individual genetic profiles and lifestyle -- to empower individuals to make better health decisions. The Cellf kit includes tests for genetic variations that influence health conditions such as insulin sensitivity, detoxification, heart and bone health, and inflammation. To date, more than 10,000 consumers have chosen to access the personalized Cellf test information.

In addition to its direct consumer channel, Sciona collaborates with large food, nutritional supplement and functional food companies in the development and commercialization of personalized genetic information useful to consumers of their proprietary nutritional products. In so doing, these companies intend to greatly increase product effectiveness by introducing unparalleled product personalization.

For more information, visit http://www.sciona.com or call 303-442-4300.

Cellf is a trademark of Sciona Ltd.

Sciona

CONTACT: Sarah Johnson, +1-303-417-6303, sarah@accent-pr.com, for Sciona



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES